Fingerpaint Group has become the first independent agency network to win Network of the Year at the 2026 Manny Awards, marking a notable shift in the competitive healthcare marketing landscape. The company also secured Best Consumer Digital Campaign, reinforcing its growing influence across life sciences commercialization, healthcare advertising, and integrated agency services.

Fingerpaint Group’s win at the 36th annual Manny Awards in New York City signals more than a trophy moment for the healthcare agency sector. It highlights how integrated commercialization models are reshaping the relationship between pharmaceutical companies and their external partners.

Traditionally, large holding-company networks have dominated top honors in healthcare marketing. Fingerpaint Group’s recognition as Network of the Year breaks that pattern and suggests that independent agency structures can now compete at scale with larger multinational groups.

The Manny Awards, one of the most recognized honors in healthcare advertising, celebrate performance across creative execution, medical communications, market access, and commercial innovation. For Fingerpaint Group, the award reflects a strategy centered on combining disciplines that have historically operated in silos.

The company says its operating model connects branding, marketing, medical affairs, medical communications, and market access under one platform. That matters because pharmaceutical launches have become significantly more complex. Drugmakers now need coordinated support spanning physician education, patient engagement, reimbursement strategy, omnichannel media, and regulatory communication.

Fingerpaint’s broader 2026 nominations demonstrate the range of that platform. The group received recognition across multiple divisions, including Fingerpaint Medical, Fingerpaint Market Access, and Fingerpaint Marketing. That cross-functional visibility is increasingly valuable as life sciences companies look to reduce vendor fragmentation.

According to the company, it now works with 95% of the top 20 global pharmaceutical companies. It also reports that two-thirds of clients engage multiple service lines. That suggests a rising demand for fewer, more strategic partners capable of handling multiple commercialization functions.

This trend aligns with wider market research. McKinsey & Company has noted that commercial excellence in pharma increasingly depends on cross-functional orchestration rather than isolated marketing execution. Meanwhile, Gartner has repeatedly emphasized integrated customer experience models as a growth lever for enterprise organizations managing complex buyer journeys.

For healthcare marketers, that shift is practical. A product launch today may require AI-powered audience segmentation, payer communications, patient adherence programs, CRM automation, medical content review workflows, and omnichannel media activation. Agencies that can coordinate these pieces inside one ecosystem can potentially move faster and reduce operational friction.

Fingerpaint’s latest win also reflects how digital capability has become central to healthcare communications. Its Best Consumer Digital Campaign award underscores growing investment in direct-to-consumer engagement, personalized media experiences, and measurable performance campaigns. As privacy regulations tighten and media channels fragment, healthcare brands increasingly need first-party data strategies and advanced analytics similar to those used in mainstream martech environments.

The company’s rise comes during broader consolidation in healthcare marketing. Many agencies have pursued mergers or specialized acquisitions to build end-to-end capability. Fingerpaint appears to be positioning itself differently: not as a loose federation of acquired brands, but as a connected operating system for commercialization.

That distinction may matter. Enterprise buyers often complain that agency networks promise integration but deliver disconnected teams, separate profit centers, and inconsistent execution. A unified structure can be a competitive advantage if it improves accountability and speed.

CEO Bill McEllen framed the award as validation of a people-led strategy supported by technology and collaboration. The company also says it has promoted leadership internally, an approach that can help preserve culture during rapid expansion.

For competitors, Fingerpaint’s win is a signal that independent firms with strong specialization and integrated delivery models can now challenge established networks. For pharmaceutical companies, it expands the shortlist of partners capable of supporting global launches and ongoing brand growth.

The bigger takeaway is that healthcare marketing is no longer just about campaigns. It is about commercialization infrastructure — the combination of data, messaging, market access expertise, medical credibility, and digital execution required to bring therapies to market efficiently.

Fingerpaint Group’s Manny Awards performance suggests that agencies built around that model may define the next phase of healthcare communications.

Market Landscape

Healthcare marketing is undergoing structural change as pharmaceutical companies seek fewer vendors with broader capabilities. Rising launch costs, tighter regulatory scrutiny, AI-driven personalization, and omnichannel engagement are pushing demand for integrated commercialization partners. Agencies competing in this space increasingly overlap with enterprise martech providers, CRM ecosystems such as Salesforce, analytics platforms, and content supply chains powered by Adobe and Microsoft technologies.

Top Insights

• Fingerpaint Group became the first independent agency to win Manny Awards Network of the Year, challenging legacy healthcare holding-company dominance.
• The company also won Best Consumer Digital Campaign, highlighting the growing importance of digital healthcare engagement strategies.
• Fingerpaint says it works with 95% of the top 20 pharma companies, indicating strong enterprise market penetration.
• Two-thirds of clients use multiple services, showing demand for integrated marketing, medical, and market access solutions.
• The win reflects a broader industry move toward commercialization platforms instead of siloed agency relationships.

Get in touch with our MarTech Experts